Clinical Trial Update: Pilot Study for Use of Dysport in Treatment of Vocal Tics in Patients With Tourette's Syndrome [NA]

View source ↗

Summary

A pilot clinical trial is evaluating Dysport (abobotulinumtoxinA) for treating vocal tics in Tourette syndrome. The trial status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motor or Vocal Tic Disorder
• Tourette Syndrome

Drugs mentioned

• Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Detroit Clinical Research Center | Conditions: Tourette Syndrome, Chronic Vocal Tic | NA | Status: UNKNOWN